StockGlow

Eli Lilly and Company (LLYC.VI)

Eli Lilly and Company discovers, develops, manufactures, and markets human pharmaceutical products in the United States, Europe, China, Japan, and internationally.

997.70-0.01%Healthcare
Compare LLYC.VI with
StockGlow Score
71
Leaning Bullish
BearishBullish
1 year ago+52.2%

The outlook

Eli Lilly and Company currently reads as leaning bullish based on mixed vs its moving averages, 84% of the way from its 52-week low to high. This is a snapshot of current market data, not a forecast.

What’s behind the score

Price trendMixed vs its moving averages
52-week range84% of the way from its 52-week low to high
Market cap
$889.69B
52-wk high
1,085.40
52-wk low
539.10
50-day avg
1,004.73
200-day avg
885.09
Trailing P/E
40.3

Similar stocks

LLY.DEEli Lilly and Company$982.10-2.38%LLY.FEli Lilly and Company$978.90-2.89%JNJ.VIJohnson & Johnson$222.45+0.11%MRK.VIMerck & Co., Inc.$112.00+0.45%ABBV.VIAbbVie Inc.$223.60+0.45%

The StockGlow Score is a snapshot of current, observable market data (analyst ratings, price trend, 52-week range) — not a prediction, forecast, or recommendation. Informational only, not investment advice. Data from public sources and may be delayed. How this works·Privacy